JPH0135840B2 - - Google Patents

Info

Publication number
JPH0135840B2
JPH0135840B2 JP55501235A JP50123580A JPH0135840B2 JP H0135840 B2 JPH0135840 B2 JP H0135840B2 JP 55501235 A JP55501235 A JP 55501235A JP 50123580 A JP50123580 A JP 50123580A JP H0135840 B2 JPH0135840 B2 JP H0135840B2
Authority
JP
Japan
Prior art keywords
fragment
glu
group
ddz
thymosin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55501235A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56500655A (OSRAM
Inventor
Kurisuchian Biru
Ururitsuhi Shutorenueruku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORUPEGEN MEDEITSUINISHUUMOREKURAARUBIOROGITSUSHE FUORUSHUNGUSUKEZERUSHAFUTO MBH
Original Assignee
ORUPEGEN MEDEITSUINISHUUMOREKURAARUBIOROGITSUSHE FUORUSHUNGUSUKEZERUSHAFUTO MBH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ORUPEGEN MEDEITSUINISHUUMOREKURAARUBIOROGITSUSHE FUORUSHUNGUSUKEZERUSHAFUTO MBH filed Critical ORUPEGEN MEDEITSUINISHUUMOREKURAARUBIOROGITSUSHE FUORUSHUNGUSUKEZERUSHAFUTO MBH
Publication of JPS56500655A publication Critical patent/JPS56500655A/ja
Publication of JPH0135840B2 publication Critical patent/JPH0135840B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57581—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP55501235A 1979-05-15 1980-05-14 Expired JPH0135840B2 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792919592 DE2919592A1 (de) 1979-05-15 1979-05-15 Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon

Publications (2)

Publication Number Publication Date
JPS56500655A JPS56500655A (OSRAM) 1981-05-14
JPH0135840B2 true JPH0135840B2 (OSRAM) 1989-07-27

Family

ID=6070778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55501235A Expired JPH0135840B2 (OSRAM) 1979-05-15 1980-05-14

Country Status (8)

Country Link
US (2) US4353821A (OSRAM)
EP (1) EP0028627B1 (OSRAM)
JP (1) JPH0135840B2 (OSRAM)
CH (1) CH649089A5 (OSRAM)
DE (1) DE2919592A1 (OSRAM)
GB (1) GB2065662B (OSRAM)
NL (1) NL8020195A (OSRAM)
WO (1) WO1980002560A1 (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033384B1 (de) * 1980-01-18 1984-02-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Thymosin-alpha-1-Fragmente enthaltende Arzneimittel mit immunstimulierender Wirkung, und Thymosin-alpha-1-Fragmente
DE3137231A1 (de) * 1981-09-18 1983-04-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Bis-thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-verbindungen
US4497801A (en) * 1982-09-17 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. New peptides, process for preparation thereof and use thereof
US4581168A (en) * 1983-02-21 1986-04-08 Sanofi Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
US4517119A (en) * 1983-04-04 1985-05-14 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4504415A (en) * 1983-04-04 1985-03-12 Hoffman-La Roche Inc. Synthesis of thymosin α1 and desacetyl thymosin α1
FR2551088B1 (OSRAM) * 1983-08-29 1985-12-06 Pasteur Institut
US4983387A (en) * 1986-05-19 1991-01-08 Viral Technologies Inc. HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
ZA873215B (en) * 1986-05-19 1987-10-28 Viral Technologies Inc. Htlv-iii/lav virus related peptides,antibodies to the peptides,vaccines,passive and active immunization against aids virus and diagnostic test for the serological detection of aids virus
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
AU6359594A (en) * 1993-03-04 1994-09-26 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US6262230B1 (en) * 1994-01-28 2001-07-17 Sciclone Pharmaceuticals Inc. Analogs of thymosin α1
US5632983A (en) 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
AU2001268326A1 (en) * 2000-06-14 2001-12-24 Chanda Zaveri Peptides with physiological activity
US20070031372A1 (en) * 2004-08-05 2007-02-08 Hadden John W Vaccine immunotherapy for immune suppressed patients
US20070154399A1 (en) * 2000-10-27 2007-07-05 Hadden John W Immunotherapy for immune suppressed patients
US20060194242A1 (en) * 2000-10-27 2006-08-31 Hadden John W Immunotherapy for immune suppressed patients
US7182942B2 (en) * 2000-10-27 2007-02-27 Irx Therapeutics, Inc. Vaccine immunotherapy for immune suppressed patients
US20070025958A1 (en) * 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
EP1337149A4 (en) 2000-10-27 2005-10-12 Irx Therapeutics Inc VACCINE IMMUNOTHERAPY FOR IMMUNE-PATIENT PATIENTS
US20050020495A1 (en) * 2001-10-24 2005-01-27 Martins Eduardo Bruno Guimaraes Antiretroviral compositions comprising thymosin alpha peptides and protease inhibitors
JP2005510491A (ja) * 2001-10-26 2005-04-21 イミュノ−アールエックス， インコーポレイテッド 免疫抑制を逆転させるための免疫治療
CN1269524C (zh) * 2001-10-26 2006-08-16 罗得岛医院 胸腺素强化的遗传免疫方法
UA78726C2 (en) * 2001-11-01 2007-04-25 Sciclone Pharmaceuticals Inc Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment
UA77999C2 (en) * 2001-12-10 2007-02-15 Thymosin-alpha 1 for treatment of malignant glioblastoma
CN100501400C (zh) 2002-11-25 2009-06-17 希克龙制药公司 使用α胸腺素防护辐射损伤的方法
UA80870C2 (en) * 2003-03-28 2007-11-12 Sciclone Pharmaceuticals Inc Method for treatment or prevention of aspergillus infections with thymosin alpha 1
US20100311656A1 (en) * 2003-04-23 2010-12-09 Sciclone Pharmaceuticals, Inc. Treatment or prevention of respiratory viral infections with alpha thymosin peptides
MXPA06000517A (es) * 2003-07-18 2006-07-10 Regenerx Biopharmaceuticals Composiciones y metodos para el tratamiento o prevencion de dano debido a la exposicion a radiacion.
WO2009070639A1 (en) 2007-11-28 2009-06-04 Irx Therapeutics, Inc. Method of increasing immunological effect
ES2679043T3 (es) 2009-05-15 2018-08-21 Irx Therapeutics, Inc. Inmunoterapia de vacuna
CN107050430B (zh) 2009-12-08 2021-10-15 伊尔克斯治疗有限公司 逆转朗格汉斯细胞免疫抑制的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
CH633258A5 (en) * 1976-10-28 1982-11-30 Hoffmann La Roche Process for preparing thymosin alpha 1
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
CH641152A5 (en) * 1977-04-22 1984-02-15 Hoffmann La Roche Process for preparing thymosin alpha-1 and an analogue
US4148788A (en) * 1978-01-23 1979-04-10 Hoffmann-La Roche Inc. Synthesis of thymosin α1
DE2830442A1 (de) * 1978-07-11 1980-01-24 Max Planck Gesellschaft Verfahren zur herstellung von polypeptiden

Also Published As

Publication number Publication date
WO1980002560A1 (en) 1980-11-27
CH649089A5 (de) 1985-04-30
US4466918A (en) 1984-08-21
GB2065662A (en) 1981-07-01
US4353821A (en) 1982-10-12
NL8020195A (nl) 1981-02-27
EP0028627A1 (de) 1981-05-20
GB2065662B (en) 1983-03-30
JPS56500655A (OSRAM) 1981-05-14
DE2919592A1 (de) 1981-01-15
DE2919592C2 (OSRAM) 1992-01-16
EP0028627B1 (de) 1984-05-09

Similar Documents

Publication Publication Date Title
JPH0135840B2 (OSRAM)
Marshall et al. Synthesis of angiotensins by the solid-phase method
FI94350C (fi) Menetelmä T-soluavustaja-aktiivisuutta omaavien peptidien valmistamiseksi
KR940001007B1 (ko) 펩타이드의 제조방법
US4190646A (en) Polypeptide compositions and methods
DK149754B (da) Analogifremgangsmaade til fremstilling af et dermorphinanalogt tetra-, penta-, hexa- eller heptapeptidderivat eller et farmaceutisk acceptabelt salt deraf
JPH0378374B2 (OSRAM)
Blake et al. THE SOLID‐PHASE SYNTHESIS OF ALPHA‐MELANOTROPIN
US4396605A (en) Bis-thymosine α-1 compounds
US4397842A (en) Peptides having thymopoietin-like activity
CA1105925A (en) Pentapeptide compositions and methods
JPS60226898A (ja) 新規ゴナドリベリン誘導体およびその製造方法
WO1994018233A1 (en) Thymosin alpha-1 derivatives
EP0018182A1 (en) Peptides having thymopoietin-like activity, therapeutic compositions containing them, and process for their preparation
CN107141350A (zh) 一种胰岛素类似物及其合成方法
CA1315470C (en) Allylic side chain-containing solid phase systems, processes for the preparation thereof and the use thereof in solid phase reactions
Rocchi et al. Synthesis of peptide analogs of the N-terminal eicosapeptide sequence of ribonuclease A. XIII. Synthesis of des-Lys7-[Orn10]-and des-Phe8-[Orn10]-S-peptides
SE446866B (sv) Sett att framstella en aktiv polypeptid med formaga att inducera differentiering av bade t-lymfocyter och komplementreceptor (cr?72+) b-lymfocyter
US4258152A (en) Pentapeptide modified resin
US3847892A (en) Octapeptide solid phase-fragment process and pentapeptide intermediates
FI96115B (fi) Menetelmä peptidien valmistamiseksi, joilla on T-soluavustaja-aktiivisuutta
CN118359680A (zh) 一种Semglutide衍生订书肽及其制备方法和应用
JPS6126919B2 (OSRAM)
KR20250116767A (ko) 변형 구조가 있는 폴리펩타이드 및 그 용도
JPS6354396A (ja) Ｓ―ポリプレニルペプチド